X
11Nov

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells | | Return|
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By: Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/

Related

NLRB Tunes Up Appropriate Standard in Determining Bargaining Unit of Mechanics at Boeing

The National Labor Relations Board (NLRB) has held that a unit selected for organizing by the Intern...

Read More >

Trump Administration Finalizes Major Changes to Endangered Species Act Regulations

The U.S. Fish and Wildlife Service and National Marine Fisheries Service issued a set of three new f...

Read More >

NLRB: Employers Win When Their Employees Can’t “Opt-In”

In the first post-Epic Systems decision regarding arbitration agreements, the NLRB has underscored j...

Read More >

International News: Private Equity - December 2019

A recent McDermott round table on European health private equity generated key insights into the fut...

Read More >

Nicaragua - Increase in minimum wage for 2020

On February 6, 2020, Nicaraguan Ministry of Labor issued the Ministerial Agreement number ALTB-01-02...

Read More >

Construction Industry Employers, Take Heed: “Willful” OSHA Violations May Lead to Criminal Penalties

The U.S. government recently reminded employers that the consequences stemming from worker safety vi...

Read More >